Abstract
It is well known that bleomycin, developed by Umezawa et al. in 1965, is now widely used not only in Japan but also in other countries as an anticancer drug, specifically effective against squamous cell carcinoma and malignant lymphoma, giving excellent clinical effects. It is, however, accompained by the occurrence of pulmonary fibrosis as one of its adverse effects, creating problems as to the measures to counteract it.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brochure of preclinical studies of NK631. Institute of Microbial Chemistry (1976) Brochure of preclinical studies of NK631. Nippon Kayaku, Tokyo
Karnofsky DA (1961) Meaningful clinical classification of therapeutic response to anticancer drugs. Clin Pharmacol Ther 2:709–712
Miura T, Ishida M (1974) Effects of triple agent chemotherapy with mitomycin C, 5-FU and cylocide in 31 cases of various tumors; i.a. therapy using uronase. Jpn J Cancer Clin 20:255–263
Miura T, Wada T, Katayama K, Miyahara T, Hashimoto D, Konishi T, Haida K, Haida S (1977) Surgical chemotherapy of colonic cancer. Cancer Chemother 4:971–982
Miura T, Wada T (1978) Evaluation of chemotherapy of hepatic carcinoma, with particular reference to chemotherapy by selective infusion into the hepatic artery. Surg Diagn Treat 20:144–154
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Miura, T., Katayama, K., Wada, T. (1981). Phase I and II Study of a New Bleomycin Analog (Pepleomycin). In: Carter, S.K., Sakurai, Y., Umezawa, H. (eds) New Drugs in Cancer Chemotherapy. Recent Results in Cancer Research, vol 76. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81565-2_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-81565-2_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81567-6
Online ISBN: 978-3-642-81565-2
eBook Packages: Springer Book Archive